Antimicrobial Resistance and Infection Control · 2018 · 129 citations · 22 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial Use SurveillanceCarbapenem ResistanceResistance In Gram-negative BacteriaResistance In Gram-positive BacteriaAntibiotic Utilization MeasurementAntimicrobial Utilization EvaluationCarbapenem Resistance SurveillanceEscherichia ColiHospital Antimicrobial Resistance SurveillanceHospital Antimicrobial UtilizationNational Antimicrobial Consumption Surveillance
Abstract Background This study aimed to investigate the relationship between the rate of carbapenem-resistant Gram-negative bacteria and antibiotic consumption intensity in 153 tertiary hospitals from China in 2014. Methods A retrospective study using national surveillance data from 2014 was conducted. Data on the annual consumption of each antibiotic, as well as the rate of carbapenem-resistant Gram-negative bacteria, were collected from each participating hospital, and the correlation between antibiotic consumption and carbapenem- resistant rate was analyzed. Results The overall antibiotic consumption intensity among the hospitals varied between 23.93 and 86.80 defined daily dosages (DDDs) per 100 patient-days (median, 46.30 DDDs per 100 patient-days). Cephalosporins were the most commonly used antibiotic, followed by quinolones, penicillins, and carbapenems, and the rate of carbapenem-resistant Gram-negative bacteria from each hospital varied. The correlations between carbapenem consumption intensity and rate of carbapenem resistance revealed correlation factors of 0.271 for Escherichia coli ( p < 0.01), 0.427 for Klebsiella pneumoniae ( p < 0.01), 0.463 for Pseudomonas aeruginosa ( p < 0.01), and 0.331 for Acinetobacter baumannii ( p < 0.01). Conclusions A significant relationship existed between the carbapenem consumption and the rates of carbapenem-resistant gram negative bacilli. Rational use of carbapenems should be implemented to address the issue of carbapenem resistance in hospitals.
22
Marlieke E.A. de Kraker, Martin Wolkewitz, Peter Davey et al. · Journal of Antimicrobial Chemotherapy · 2010 · 278 citations · Full text
Po‐Ren Hsueh, Wen-Hwei Chen, Kwen‐Tay Luh · International Journal of Antimicrobial Agents · 2005 · 269 citations · Full text
Paul G. Higgins, Hilmar Wisplinghoff, Danuta Stefanik et al. · Journal of Antimicrobial Chemotherapy · 2004 · 120 citations · Full text